Maternal Health market is anticipated to grow at a CAGR of 9.0% during the forecast period (2023–2030). The growth of the market is attributed to the growing demand for adopting evidence-based best practices that can lead to better maternal and infant health outcomes. Nowadays, hospitals that have adopted the highest standards in terms of patient care quality, safety, and accessibility for pregnant and postpartum patients have been awarded a certification that informs consumers about the establishments. Accordingly, market players are coming up with new products to cater to the demand for new programmes. For instance, in 2022, the Centers for Medicare & Medicaid Services (CMS) launched a new programme within its maternity and baby health programme aimed at reducing low-risk caesarean deliveries in order to enhance both infant and maternal health. The core of this programme is a learning collaborative that provides Medicaid and CHIP agencies with strategies to prevent low-risk caesarean deliveries and works directly with states to adopt research-proven best practices in their state.

Segmental Outlook 

The global maternal health market is segmented by type, complication, and care. Based on type, the market is sub-segmented into intrauterine, ectopic, tubal, and others. Based on the complications, the market is sub-segmented into miscarriage, premature labor and birth, preeclampsia, gestational diabetes, placenta previa, and others. Further, on the basis of care, the market is sub-segmented into prenatal care and postnatal care. Among the complications, the miscarriage sub-segment is anticipated to hold a considerable share of the market owing to the growing demand for maternal health care as a result of an increase in miscarriages across the globe. For instance, in 2022, according to the National Institute of Health (NIH), The probability of miscarriage in women aged 20 to 30 at fewer than 20 weeks' gestation is 8.9%. When it comes to women over 40, this rises to 74.7%. Prior obstetrical history is a significant predictor of early pregnancy loss risk. After one loss, two consecutive miscarriages, or three or more consecutive miscarriages, the chance of miscarriage in a subsequent pregnancy is approximately 20%, 28%, and 43%, respectively.

The Gestational Diabetes Sub-Segment is Anticipated to Hold a Considerable Share of the Global Maternal Health Market

Among the complications, the gestational diabetes sub-segment is expected to hold a considerable share of the global maternal health market. The segmental growth is attributed to growing prevalence of gestation diabetes among population across the region. Gestational diabetes can be controlled with diet, exercise, and, in some cases, insulin therapy, depending on the severity. A chronic (long-lasting) medical condition called diabetes affects how the body converts food into energy. The goal of gestational diabetes treatment is to maintain blood glucose levels that are comparable to those of pregnant women without the condition. Special meal regimens, regular exercise schedules, daily blood glucose tests, and insulin injections are all part of the treatment. According to the Centers for Disease Control and Prevention, if a woman is not suffering from diabetes, she can develop gestational diabetes during pregnancy. Gestational diabetes affects somewhere between 2% and 10% of pregnancies each year in the US. Maintaining control of gestational diabetes ensures a safe pregnancy and a healthy delivery.

Regional Outlook

The global Maternal Health market is further segmented based on geography, including North America (the US and Canada), Europe (the UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and the Rest of Asia), and the Rest of the World (the Middle East and Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the increase in public health consciousness and a rise in demand for innovative medical technologies.

Global Maternal Health Market Growth by Region 2023-2030

The North America Region is Expected to Grow at a Significant CAGR in the Global Maternal Health Market

Among all regions, North America is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to growing demand for family planning across the region. Women who possess the opportunity to utilize contraception and family planning services can space their pregnancies and lower their risk of difficulties. Accordingly, market players are coming up with new products to cater to the demand for maternal death rates. According to the Centers for Disease Control and Prevention, this report updates an earlier one that showed maternal death rates for the years 2018 to 2020. In the US, 1,205 women passed away owing to pregnancy-related causes in 2021, as opposed to 861 in 2020 and 754 in 2019. Compared to rates of 23.8 deaths per 100,000 live births in 2020 and 20.1 deaths per 100,000 live births in 2019, the maternal mortality rate for 2021 was 32.9. In 2021, non-Hispanic Black (thus, Black) women had a maternal mortality rate of 69.9 deaths per 100,000 live births, that was 2.6 times higher than the rate for non-Hispanic White (thus, White) women (26.6). Black women's rates were significantly higher than those of White and Hispanic women. Between 2020 and 2021, there were significant increases in individuals of Hispanic heritage and all other racial groups.

The Maternal Mortality Rate

Source: Centres for Disease Control and Prevention

In 2018, the maternal mortality rate was 17.4 deaths per 100,000 live births, in 2019 it was 20.1 deaths per 100,000 live births, in 2020 it was 23.8 deaths per 100,000 live births, and in 2021 it was 32.9 deaths per 100,000 live births.

Market Players Outlook

The major companies serving the Maternal Health market include Agile Therapeutics, Inc., Boston MedTech Advisors, Inc., Fuji Latex Co., Ltd., Johnson & Johnson Services, Inc., March of Dimes and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in December 2022, The New Jersey Health Care Quality Institute, in partnership with the Burke Foundation, launched the Maternal Infant Health (MIH) Hub, an innovative policy and learning partnership with a mission to advance midwifery practice in New Jersey while enhancing maternal/infant health and reducing racial/ethnic inequities.

The Report Covers

• Market value data analysis of 2022 and forecast to 2030.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global maternal health market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.